NICE recommends SGLT-2 inhibitors with metformin at diagnosis, citing major cardiovascular, renal, and mortality benefits.

People diagnosed with type 2 diabetes before age 40 face a higher lifetime risk of heart and kidney problems, so may benefit from adding another type of medicine called a GLP-1 receptor agonist (such ...

Most people with type 2 diabetes should be offered SGLT-2 inhibitors much earlier in their treatment, final NICE guidance has ...

Dietary advice and structured lifestyle interventions remain central to the effective management of Type 2 diabetes, with clinical guidelines emphasising the need for individualised, ...

Statistics indicate that type 2 diabetes (T2D) affects approximately 14% of the global population. This is significant ...

The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available for ...

The American College of Lifestyle Medicine (ACLM) has published the first clinical practice guideline to put lifestyle interventions at the forefront of type 2 diabetes and prediabetes care.

Nutritional interventions, particularly supplements, are associated with significant improvements in anxiety among patients with T2D.